Skip to main content

Hemodynamic Effects of Activated Protein C in Septic Shock

  • Conference paper
Intensive Care Medicine
  • 941 Accesses

Abstract

Recombinant human activated protein C (rhAPC) has been demonstrated to reduce the mortality rate of adult patients with severe sepsis [1]. This effect is thought to be related to a reduction in coagulation and, to a lesser extent, to a reduction in the inflammatory response to sepsis. Data from the Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study demonstrated that the use of rhAPC was associated with a quicker reduction in cardiovascular failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernard GR, Vincent JL, Laterre PF, et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  CAS  Google Scholar 

  2. Monnet X, Lamia B, Anguel N, Richard C, Bonmarchand G, Teboul JL (2005) Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients. Intensive Care Med 31:1573–1576

    Article  PubMed  CAS  Google Scholar 

  3. Kalil AC, Coyle SM, Um JY, et al (2004) Effects of drotrecogin alfa (activated) in human endotoxemia. Shock 21:222–229

    Article  PubMed  CAS  Google Scholar 

  4. Derhaschnig U, Reiter R, Knobl P, Baumgartner M, Keen P, Jilma B (2003) Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood 102:2093–2098

    Article  PubMed  CAS  Google Scholar 

  5. Isobe H, Okajima K, Uchiba M, et al (2001) Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104:1171–1175

    Article  PubMed  CAS  Google Scholar 

  6. Favory R, Lancel S, Marechal X, Tissier S, Neviere R (2006) Cardiovascular protective role for activated protein C during endotoxemia in rats. Intensive Care Med 32:899–905

    Article  PubMed  Google Scholar 

  7. Sennoun S, Desebbe O, Barraud D, Gibot S, Levy B (2006) Hemodynamic effects of activated protein C. Intensive Care Med 32:S74 (abst)

    Google Scholar 

  8. Nick JA, Coldren CD, Geraci MW, et al (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878–3885

    Article  PubMed  CAS  Google Scholar 

  9. Abraham E (2005) Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2:243–247

    Article  PubMed  CAS  Google Scholar 

  10. Dahlback B, Villoutreix BO (2005) Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol 25:1311–1320

    Article  PubMed  Google Scholar 

  11. Macias WL, Yan SB, Williams MD, et al (2005) New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). Crit Care 9(Suppl 4):S38–45

    Article  PubMed  Google Scholar 

  12. Dahlback B, Villoutreix BO (2005) The anticoagulant protein C pathway. FEBS Lett 579: 3310–3316

    Article  PubMed  Google Scholar 

  13. Mizutani A, Okajima K, Uchiba M, Noguchi T (2000) Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95: 3781–3787

    PubMed  CAS  Google Scholar 

  14. Hoffmann JN, Vollmar B, Laschke MW, et al (2004) Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32:1011–1017

    Article  PubMed  Google Scholar 

  15. Uchiba M, Okajima K, Oike Y, et al (2004) Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo. Circ Res 95:34–41

    Article  PubMed  CAS  Google Scholar 

  16. Isobe H, Okajima K, Harada N, Liu W, Okabe H (2004) Activated protein C reduces stress-induced gastric mucosal injury in rats by inhibiting the endothelial cell injury. J Thromb Haemost 2:313–320

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science + Business Media Inc.

About this paper

Cite this paper

Sennoun, N., Desebbe, O., Levy, B. (2007). Hemodynamic Effects of Activated Protein C in Septic Shock. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-49518-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-49518-7_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-49517-0

  • Online ISBN: 978-0-387-49518-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics